Rein Therapeutics
Price & Volume
Stats
See more52W Range | $1.04-$4.40 |
Market Cap | $52.8M |
Shares Short | 21,324 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.88 |
News
See moreYahoo Finance • 15 days ago
Rein Therapeutics Announces Publication of New Translational Data in iScience on Company’s Novel Therapy for Idiopathic Pulmonary Fibrosis
Yahoo Finance • 29 days ago
Rein Therapeutics files to sell 10M shares of common stock for holders
Yahoo Finance • last month
UK regulator approves Rein Therapeutics' phase 2 trial for IPF drug
About
CEO | Dr. James Brian Windsor Ph.D. |
Address | 12407 N. Mopac Expy., Austin, TX, United States, 78758 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |
